长链非编码RNA LOC101927476抑制卵巢癌细胞系的侵袭、迁移和增殖
该研究检测了长链非编码RNA LOC101927476在卵巢癌细胞系、22例原发瘤与匹配转移瘤组织及TCGA数据中的表达,并通过过表达和敲除实验观察其对侵袭、迁移和增殖的影响。结果显示LOC101927476在转移灶中表达低于原发灶,过表达可抑制3AO细胞侵袭、迁移和增殖,敲除则增强OVCA429细胞上述能力,且与GATA4表达相关。
要点
- 22例卵巢癌患者中20例转移灶LOC101927476表达低于原发灶。
- 过表达LOC101927476抑制3AO细胞侵袭、迁移和增殖。
- 敲除LOC101927476增强OVCA429细胞侵袭、迁移和增殖。
核心结论
- LncRNA LOC101927476能够抑制卵巢癌的侵袭、迁移和增殖。
研究设计与样本
- 选取2018—2019年于中国医学科学院肿瘤医院手术治疗的卵巢癌患者,检测卵巢癌细胞系及22例原发瘤和匹配转移瘤组织中LOC101927476表达。
- 采用TCGA数据库卵巢癌转录组测序数据验证LOC101927476和GATA4表达。
- 用慢病毒构建过表达LOC101927476(OE-LOC101927476组)和空载(OE-EV组)并转染3AO细胞,利用CRISPR/Cas9构建LOC101927476敲除OVCA429细胞系。
- 采用Transwell法、划痕实验和CCK-8法检测侵袭、迁移和增殖能力。
主要发现
- real-time PCR显示22例卵巢癌患者中20例转移灶LOC101927476表达水平低于原发灶。
- Transwell迁移实验:OE-EV组3AO穿膜细胞数(1 024±76)个 vs OE-LOC101927476组(699±65)个(P=0.003);sg-Control组OVCA429穿膜细胞数(363±27)个 vs sg-LOC101927476组(472±40)个(P=0.011)。
- Transwell侵袭实验:OE-EV组3AO穿膜细胞数(661±95)个 vs OE-LOC101927476组(357±63)个(P=0.006);sg-Control组OVCA429穿膜细胞数(309±13)个 vs sg-LOC101927476组(512±72)个(P=0.005)。
- 划痕实验:培养48 h时OE-LOC101927476组3AO划痕愈合比例(10.86±0.63)% vs OE-EV组(57.38±4.42)%(P=0.009);培养24 h时sg-LOC101927476组OVCA429划痕愈合比例(59.98±1.34)% vs sg-Control组(23.15±2.03)%(P=0.004)。
- CCK-8:过表达后第4天OE-LOC101927476组3AO吸光度值(2.07±0.08) vs OE-EV组(2.29±0.04)(P=0.009);敲降后第4天sg-LOC101927476组OVCA429吸光度值(2.13±0.03) vs sg-Control组(1.93±0.03)(P=0.001);OE-LOC101927476组3AO中GATA4相对表达水平(1.86±0.25) vs OE-EV组(1.00±0.00)(P=0.001);LOC101927476高表达患者GATA4表达水平(2.93±0.35) vs 低表达患者(0.29±0.06)(P=0.001)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the expression of long non-coding RNA LOC101927476 (LncRNA LOC101927476) in ovarian cancer and its effect on the biological characteristics of ovarian cancer. Methods: Patients with ovarian cancer who underwent surgery in Cancer Hospital of Chinese Academy of Medical Sciences from 2018 to 2019 were selected. The expressions of LOC101927476 in ovarian cancer cells 3AO, OVCA429, TOV21G, A2780, SKOV3, as well as 22 primary tumor tissues and their matched metastatic tumor tissues were detected by real-time quantitative polymerase chain reaction (RT-PCR). Ovarian cancer transcriptome sequencing data from the TCGA database was used to verify the expressions of LOC101927476 and GATA4. 3AO and OVCA429 cells were infected with lentivirus plasmid containing OE-LOC101927476 and single guide RNA (sg-RNA) targeting LOC101927476, respectively. The effects of LOC101927476 on migration and invasion were detected by Transwell and wound healing assay. The effect of LOC101927476 on cell proliferation was detected by cell counting kit-8 (CCK-8) assay. Results: RT-PCR assay showed that 20 out of 22 patients had significantly lower expression of LOC101927476 in their metastatic tumors compared with primary tumors. Transwell assay showed that overexpression of LOC101927476 significantly inhibited the invasion and migration capacities of 3AO cells. The numbers of invading and migrating 3AO cells infected with OE-LOC101927476 lentivirus were (357±63) and (699±65), respectively, lower than (661±95) and (1 024±76) in OE-EV group (P<0.050). In contrast, the numbers of invading and migrating OVCA429 cells with LOC101927476 knockdown were (512±72) and (472±40), respectively, higher than (309±13) and (363±27) in sg-Control group (P<0.050). Wound healing assay results showed that after 48 hours, the percentage of scratch healing of 3AO cells in OE-LOC101927476 group was (10.86±0.63)%, significantly lower than (57.38±4.42)% of OE-EV group (P=0.009). After 24 hours, the percentage of scratch healing of OCVA429 cells in sg-LOC101927476 group was (59.98±1.34)%, significantly higher than (23.15±2.03)% of sg-Control group (P=0.004). CCK-8 assays showed that the OD value of 3AO cells in OE-LOC101927476 group was (2.07±0.08), significantly lower than (2.29±0.04) of OE-EV group (P=0.009). The OD value of OVCA429 cells in sg-LOC101927476 group was (2.13±0.03), significantly higher than (1.93±0.03) of sg-Control group (P=0.001). The relative expression of GATA4 in OE-LOC101927476 group was (1.86±0.25), significantly higher than 1.00 of OE-EV group (P=0.001). In patients with high expression of LncRNA LOC101927476, the expression level of GATA4 was (2.93±0.35), which was higher than (0.29±0.06) of LOC101927476 low expression group (P=0.001). Conclusion: LncRNA LOC101927476 can inhibit the invasion, migration and proliferation of ovarian cancer cells. 目的: 探讨长链非编码RNA(LncRNA)LOC101927476在卵巢癌细胞中的表达及其对卵巢癌生物学特征的影响。 方法: 选取2018—2019年于中国医学科学院肿瘤医院手术治疗的卵巢癌患者。采用实时荧光定量PCR(real-time PCR)检测卵巢癌细胞系3AO、OVCA429、TOV21G、A2780、SKOV3以及22例卵巢癌原发瘤和转移瘤组织中LncRNA LOC101927476的表达水平,采用TCGA数据库中卵巢癌转录组测序数据验证LncRNA LOC101927476和GATA4的表达,采用慢病毒包装体系构建过表达LOC101927476(OE-LOC101927476组)和空载(OE-EV组)慢病毒并转染至3AO细胞。设计单链向导RNA(sgRNA),利用CRISPR/Cas9构建LncRNA LOC101927476敲除细胞系。采用Transwell法和划痕实验检测LncRNA LOC101927476对卵巢癌细胞侵袭和转移能力的影响。采用细胞计数盒8(CCK-8)法检测细胞的增殖能力。 结果: real-time PCR显示,22例卵巢癌患者中,20例转移灶中LncRNA LOC101927476的表达水平低于原发灶。Transwell迁移实验显示,OE-EV组3AO细胞的穿膜细胞数为(1 024±76)个,高于OE-LOC101927476组[(699±65)个,P=0.003];sg-Control组OVCA429细胞的穿膜细胞数为(363±27)个,低于sg-LOC101927476组[(472±40)个] ,差异有统计学意义(P=0.011)。Transwell侵袭实验显示,OE-EV组3AO细胞的穿膜细胞数为(661±95)个,高于OE-LOC101927476组[(357±63)个],差异有统计学意义(P=0.006);sg-Control组OVCA429细胞的穿膜细胞数为(309±13)个,低于sg-LOC101927476组[(512±72)个] ,差异有统计学意义(P=0.005)。划痕实验显示,培养48 h时,OE-LOC101927476组3AO细胞的划痕愈合比例为(10.86±0.63)%,低于OE-EV组[(57.38±4.42)%],差异有统计学意义(P=0.009);培养24 h时,sg-LOC101927476组OVCA429细胞的划痕愈合比例为(59.98±1.34)%,高于sg-Control组[(23.15±2.03)%],差异有统计学意义(P=0.004)。CCK-8结果显示,OE-LOC101927476组3AO细胞的增殖能力明显减弱,在过表达LncRNA LOC101927476后第4天时,OE-LOC101927476组3AO细胞的吸光度(A)值为2.07±0.08,与OE-EV组(2.29±0.04)比较,差异有统计学意义(P=0.009)。sg-LOC101927476组OVCA429细胞的增殖能力提高,在敲降LncRNA LOC101927476的表达后第4天时,sg-LOC101927476组OVCA429细胞的A值为(2.13±0.03),与sg-Control组(1.93±0.03)比较,差异有统计学意义(P=0.001)。OE-LOC101927476组3AO细胞中GATA4的相对表达水平为1.86±0.25,与OE-EV组(1.00±0.00)比较,差异有统计学意义(P=0.001)。在LncRNA LOC101927476高表达的患者中,GATA4的表达水平为(2.93±0.35),高于LncRNA LOC101927476低表达的患者(0.29±0.06),差异有统计学意义(P=0.001)。 结论: LncRNA LOC101927476能够抑制卵巢癌的侵袭、迁移和增殖。.
引用
- Zhao PF, Nan YB, Wang YT, et al. [Long non-coding RNA LOC101927476 inhibits invasion, migration, and proliferation of ovarian cancer cell lines]. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35073656. doi:10.3760/cma.j.cn112152-20200212-00084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。